IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FRANCESCHINI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.460
EU - Europa 11.513
AS - Asia 10.914
SA - Sud America 2.077
Continente sconosciuto - Info sul continente non disponibili 561
AF - Africa 274
OC - Oceania 26
AN - Antartide 1
Totale 44.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.969
IT - Italia 5.202
SG - Singapore 3.852
CN - Cina 3.285
BR - Brasile 1.707
UA - Ucraina 1.486
HK - Hong Kong 1.258
DE - Germania 1.208
VN - Vietnam 733
FR - Francia 669
FI - Finlandia 609
GB - Regno Unito 546
BD - Bangladesh 539
RU - Federazione Russa 422
TR - Turchia 387
IE - Irlanda 375
IN - India 258
CA - Canada 231
PL - Polonia 209
NL - Olanda 159
SE - Svezia 136
AR - Argentina 129
MX - Messico 121
ZA - Sudafrica 92
ES - Italia 91
IQ - Iraq 89
JP - Giappone 83
AT - Austria 66
PK - Pakistan 62
EC - Ecuador 53
ID - Indonesia 52
BE - Belgio 49
CO - Colombia 48
VE - Venezuela 47
SA - Arabia Saudita 41
MA - Marocco 33
CZ - Repubblica Ceca 31
JM - Giamaica 31
EG - Egitto 29
NG - Nigeria 28
UZ - Uzbekistan 28
JO - Giordania 27
LT - Lituania 27
AE - Emirati Arabi Uniti 25
EE - Estonia 25
PY - Paraguay 25
CR - Costa Rica 23
CL - Cile 22
RO - Romania 22
AU - Australia 21
AZ - Azerbaigian 20
HN - Honduras 20
HR - Croazia 20
KE - Kenya 20
CH - Svizzera 19
IL - Israele 19
PH - Filippine 19
PE - Perù 18
PT - Portogallo 18
TN - Tunisia 18
NP - Nepal 17
UY - Uruguay 17
KZ - Kazakistan 16
DZ - Algeria 15
EU - Europa 14
TT - Trinidad e Tobago 14
SK - Slovacchia (Repubblica Slovacca) 13
AL - Albania 12
GR - Grecia 12
IR - Iran 12
MK - Macedonia 11
KG - Kirghizistan 10
LB - Libano 10
LU - Lussemburgo 10
MY - Malesia 10
BG - Bulgaria 9
NI - Nicaragua 9
TH - Thailandia 9
PA - Panama 8
BO - Bolivia 7
CI - Costa d'Avorio 7
GT - Guatemala 7
HU - Ungheria 7
NO - Norvegia 7
PS - Palestinian Territory 7
RS - Serbia 7
SV - El Salvador 7
BA - Bosnia-Erzegovina 6
ET - Etiopia 6
GE - Georgia 6
LV - Lettonia 6
UG - Uganda 6
AM - Armenia 5
BH - Bahrain 5
BY - Bielorussia 5
CY - Cipro 5
DK - Danimarca 5
KR - Corea 5
PR - Porto Rico 5
AO - Angola 4
Totale 44.204
Salva come PNG Salva come JPEG
Città #
Singapore 2.019
Ashburn 1.645
Fairfield 1.572
Hong Kong 1.254
Woodbridge 1.144
San Jose 1.137
Jacksonville 1.094
Houston 843
Beijing 783
The Dalles 764
Cambridge 625
Seattle 607
Ann Arbor 587
Wilmington 578
Princeton 552
New York 535
Chandler 477
Los Angeles 472
Council Bluffs 470
Milan 455
Helsinki 371
Nanjing 352
Lauterbourg 311
Dublin 305
Istanbul 304
Dallas 301
Chicago 283
Columbus 283
Rome 269
Ho Chi Minh City 248
Brescia 240
Munich 226
Warsaw 185
Buffalo 179
Hanoi 155
Moscow 152
São Paulo 147
Des Moines 130
Santa Clara 129
San Francisco 128
Redondo Beach 127
Florence 124
Nanchang 122
San Diego 116
Shanghai 110
Hebei 105
Shenyang 105
London 98
Changsha 97
Tianjin 88
Salt Lake City 87
Turin 80
Phoenix 76
Tokyo 74
Turku 74
Jinan 73
Bologna 69
Nuremberg 67
Verona 67
Trieste 64
Brooklyn 63
Jiaxing 63
Atlanta 62
Orem 62
Lancaster 59
Rio de Janeiro 59
Toronto 58
Hangzhou 56
Chennai 55
Bergamo 54
Frankfurt am Main 53
Johannesburg 52
Montreal 52
Mexico City 49
Genoa 46
Brussels 45
Denver 45
Dearborn 43
Belo Horizonte 41
Guangzhou 41
Naples 41
Amsterdam 40
Tampa 39
Elk Grove Village 38
Kunming 35
Stockholm 34
Udine 34
Dhaka 33
Manchester 33
Ningbo 33
Romola 33
Vienna 33
Mumbai 32
Padova 32
Charlotte 31
Lappeenranta 30
Miami 30
Poplar 30
Zhengzhou 30
Palermo 29
Totale 25.862
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.396
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.863
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 709
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 497
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 248
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 224
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 223
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 222
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 220
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 208
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 208
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 199
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 198
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 197
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 195
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 194
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 190
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 189
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 186
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 184
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 182
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 182
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 181
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 179
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 179
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 178
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 177
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 175
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 174
Antiphospholipid antibodies mediate autoimmunity against dying cells. 173
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 173
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 171
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 171
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 171
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 171
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 166
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 166
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 164
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 164
The clinico-serological spectrum of overlap myositis 161
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 159
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 158
Autoimmune polyendocrine Syndromes 157
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 157
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 157
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 157
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 157
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 156
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 156
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 155
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 153
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 151
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 151
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 150
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 149
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 148
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 147
Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus 147
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 145
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 145
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 144
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 144
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 144
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 142
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 142
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 142
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 141
Anti-Ro/SSA and La/SSB antibodies 141
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 140
Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: The positive experience of a national multicentre study 139
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients 139
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 138
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 137
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 137
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 136
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 134
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 134
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 133
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 132
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 132
In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings. 132
Incidence of antiperinuclear factor in patients with psoriatic arthritis. 131
Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. 131
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 130
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 130
75-SeHCAT retention test in chronic cholestatic disease: comparison with health and effect of bile acid therapy. 130
Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors 130
Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference 130
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 130
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 130
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 129
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience. 129
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 128
Myositis autoantibodies and clinical phenotypes 128
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 128
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 128
Pathogenetic associations of maternal anti-Ro/SSA antibodies. 127
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 127
Antiperinuclear factor in psoriatic arthropathy 126
Antinuclear antibodies in psoriatic arthritis and its subgroups 126
Totale 20.614
Salva come PNG Salva come JPEG
Categoria #
all - tutte 216.929
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.929
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.424 0 0 140 176 164 200 201 234 193 296 272 548
2022/20232.266 341 38 51 99 194 564 47 229 384 56 139 124
2023/20242.853 150 84 228 246 134 458 134 138 667 94 107 413
2024/20257.324 117 156 125 734 678 592 568 343 675 585 1.492 1.259
2025/202613.956 1.224 1.862 1.068 1.878 1.336 929 2.057 583 767 1.147 688 417
2026/20271.886 783 770 333 0 0 0 0 0 0 0 0 0
Totale 44.826